Hypertension impairs blood vessels, neurons and white matter in the brain well before the condition causes a measurable rise in blood pressure, according to a new preclinical study from Weill Cornell Medicine investigators.
In 2025, four companies with Cornell-originated technologies — SafetyStratus, Bactana Corporation, Guard Medical and Halo Labs — were acquired by global corporate partners, allowing Cornell technologies to reach broader markets.
Weill Cornell Medicine scientists have uncovered the first evidence that astrocyte receptors can trigger opposite effects on cognitive function in males and females. The findings point to astrocytes as contributors to sex-specific brain mechanisms.
Weill Cornell Medicine investigators have identified an early step in a cellular process that leads to inflammation in fat cells and may result in Type 2 diabetes in people with obesity.
A Nov. 13 event sponsored by the College of Arts and Sciences will feature reflections on the political and social context and consequences of the COVID epidemic.